Planchard, D., Besse, B., Groen, H. J. M., Souquet, P., Quoix, E., Baik, C. S., . . . Johnson, B. E. (2016). An open-label phase 2 trial of dabrafenib plus trametinib in patients with previously treated BRAF V600E–mutant metastatic non-small cell lung cancer. Lancet Oncol.
Citação norma ChicagoPlanchard, David, et al. "An Open-label Phase 2 Trial of Dabrafenib Plus Trametinib in Patients With Previously Treated BRAF V600E–mutant Metastatic Non-small Cell Lung Cancer." Lancet Oncol 2016.
MLA CitationPlanchard, David, et al. "An Open-label Phase 2 Trial of Dabrafenib Plus Trametinib in Patients With Previously Treated BRAF V600E–mutant Metastatic Non-small Cell Lung Cancer." Lancet Oncol 2016.
Advarsel: Disse citationer er muligvist ikke 100% nøjagtige.